Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 8/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | PRCP | P42785 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17020400 | 0.96 | PIN1 (0.49) | PIN1ALDH1A1CYP3A4TSHRELANE | |
| SCHEMBL17020398 | 0.91 | ALDH1A1 (0.47) | PIN1ALDH1A1CYP3A4TSHRCASP3 | |
| SCHEMBL10511248 | 0.88 | CMA1 (0.49) | PIN1ELANECASP3CMA1 | |
| SCHEMBL13928441 | 0.88 | ELANE (0.49) | PIN1ELANECMA1 | |
| SCHEMBL10511588 | 0.86 | ELANE (0.46) | PIN1ELANECASP3PRCPCMA1 | |
| SCHEMBL17020369 | 0.84 | PREP (0.48) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL30139010 | 0.83 | ACE (0.49) | PIN1CASP3PRCP | |
| SCHEMBL30139044 | 0.83 | ACE (0.49) | PIN1CASP3PRCP | |
| SCHEMBL15960124 | 0.81 | PIN1 (0.54) | PIN1ELANECASP3PRCP | |
| SCHEMBL30140935 | 0.81 | ELANE (0.48) | PIN1ELANECMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150232504-A1 | ALDEHYDE CAPTURE LIGATION TECHNOLOGY FOR SYNTHESIS OF AMIDE BONDS | NEW YORK UNIVERSITY (US) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232504-A1 | ALDEHYDE CAPTURE LIGATION TECHNOLOGY FOR SYNTHESIS OF AMIDE BONDS | ALDH3A1, ALDH2, ALDH1A1 | PIN1 536/4885ALDH1A1 3/4885CYP3A4 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.